Optimal Dosing Schedule" as a peptide therapy guide where research status, sourcing, compounding quality, dosing, and clinician oversight all need extra scrutiny
PGC-1alpha Promoter Methylation in Parkinsons Disease
While this effect has been primarily observed in the GI tract, there is evidence for similar benefit in cardiovascular, neurological, and muscle tissues, suggesting that BPC-157 may be used as both a therapy in the setting of stroke and heart attack as well as a probative peptide for understanding how to promote healing following ischemic injury [5], [6]
Low incidences of seizures have been reported with oral doses in individuals with or without pre-existing seizure disorders.
This suggests that it is likely that acetylphenylhydrazine undergoes a cyclic redox reaction that results in the production of hydrogen peroxide, which in turn oxidises glutathione
Avoid extrapolating animal dose by body weight without clinical guidance